Sichuan Neijiang biopharmaceutical industry high-quality development breakthrough well-known pharmaceutical companies are increasing.

After many years of development, the inner river biopharmaceutical industry has basically formed a chemical raw materials, chemical preparations, traditional Chinese medicine, Chinese medicine tablets, biopharmaceuticals, medical equipment, sanitary materials and pharmaceutical supplies, animal medicine and other eight categories-based industrial development system, perennial production of more than 100 kinds of drugs (with) products, product types and dosage forms are relatively rich, in Sichuan Province and even Chengyu region advantagesAmong them, vitamin D2 raw material synyakness sales ranked among the world's leading, artificial cattle yellow raw material sage raw drug production and sales of the forefront of the country, music agent production and sales of more than one-third of the country"The biopharmaceutical industry is a sunrise industry, fengkou industry, the development prospects are very broadThe head of the Inner River Economic and Information Bureau said that Neijiang as an important breakthrough in the development of high-quality industrial products, the momentum of rapid development: year-round production of more than 100 kinds of pharmaceutical products, only in the first quarter of this year, the pharmaceutical manufacturing industry growth of 36.1%; At present, the Inner River Economic Zone is building 7 square kilometers of Neijiang Biopharmaceutical Industry Park, to promote the development of biopharmaceutical industry clusters, to create "Chengyu area green API manufacturing base, high-end anti-tumor drug research and development production base, modern Chinese medicine innovation base, China's southwest modern medicine logistics center." Neijiang Biopharmaceutical Industry Park is vigorously attracting biopharmaceuticals, chemical raw materials and preparations, pharmaceutical intermediates, Chinese medicine extraction and traditional Chinese medicine and other projects, and strive to introduce more than 30 enterprises by 2025, to achieve output value of more than 20 billion yuanIt is understood that on June 30, in Chengyu area green API manufacturing base and The Inner River biopharmaceutical industry promotion conference, Sichuan Huiyu Pharmaceutical Co., Ltdand The Inner River through the Kai District formally signed The Huiyu RAW materials and preparation production base project investment agreement, which marks the Neijiang Economic Development Zone in the construction of the Inner River Biopharmaceutical Industry Park pressed the "fast-forward key." Huiyu Pharmaceuticals said that at present, the company is working hard to build a green API manufacturing base in The Region, is expected to start this yearAt the same time, the company is also actively preparing to declare the board, the green API manufacturing base as the listing of the blockbusterAt the same time also signed the investment of nearly 200 million yuan Of Hengbo biosafety prevention and control products industrialization project, fully reached the post-partum, estimated annual sales of 700 million yuan, 70 million yuan in tax revenue, to solve the employment of about 240 peopleIt is reported that at the presentation, Neijiang City and pharmaceutical enterprises signed 12 key projects, covering the cultivation of traditional Chinese medicine, health care, medical protective supplies and other fields, the total investment amounted to 4.156 billion yuanIn the "four beams and eight pillars" of the Inner River industrial system, biomedicine occupies an important positionAnd the city committee to the position of biomedicine is: new medicine! A "new" word, is the city committee's high hopes for the development of bio-medicine - the development of biomedicine in the River does not take the traditional route, but the pursuit of "high, fine, sharp", focus on the development of innovative drugsAmong them, Huiyu Pharmaceuticals, Yangong Pharmaceuticals, Hengtong Pharmaceuticals, Tiande Pharmaceuticals, Kiyuan Bio and a large number of enterprises are accelerating towards high-end, internationalization, clusteringData show that in 2019, the "cake" of the new pharmaceutical industry in Neijiang is getting bigger and bigger: the total output value of 19 industrial enterprises above the scale of the biopharmaceutical industry in the city reached 3.588 billion yuan, up 37.8% year-on-yearAnd the above-mentioned achievements also originated from the river's own good bio-medicine foundation, after many years of development, the inner river biopharmaceutical industry basically formed a chemical raw materials, chemical preparations, traditional Chinese medicine, Chinese medicine tablets, biological drugs, medical equipment, health materials and pharmaceutical supplies, animal medicine and other eight categories of industry-based industrial development system, perennial production of more than 100 kinds of drugs (used), product types and dosage forms are more abundant, in Sichuan Province and even the advantages of the region